How to Value a Startup: The 3 Methods Investors Actually Use

Startup valuation is part math, part negotiation, and part storytelling. Investors are not running a single formula and presenting you with a number. They are triangulating between several methods, adjusting for market conditions and their own return requirements, and arriving at a price they are willing to defend to their LPs. Understanding how they get there makes you a better negotiator and helps you set expectations before you go into a raise.

This guide covers the three main methods investors use to value startups, when each one applies, and what inputs actually move the number in your favour. For context on how valuations are used across different stages, the complete guide to startup funding rounds shows typical valuation ranges from pre-seed through Series E.

The 3 Methods Investors Actually Use

1. The VC Method

The VC method works backwards from the expected exit. An investor decides how much they need to return to their fund, estimates what the company might be worth at exit (either acquisition or IPO), and works back to a current valuation that satisfies their return target given the dilution they expect along the way.

Here is how it works in practice. An early-stage VC invests $2 million. They need a 10x return on that investment, so they need the investment to be worth $20 million at exit. If they expect to own 15% of the company at exit (after accounting for future dilution), they need the company to be worth $133 million at that point. If they expect the company to exit in 5 years at a 5x ARR multiple, they are implying $26.6 million in ARR at exit. Working backwards from today, they price your current round to fit that model.

The VC method is most useful for Series A and later, when there is enough operating history to make exit assumptions credible. It is also the method most sensitive to the investor's fund size and return requirements, which vary widely. A $50 million seed fund and a $500 million growth fund looking at the same company will often arrive at very different numbers using the same method.

2. Revenue Multiples and Comparable Transactions

For companies with revenue, the most common approach is to look at what comparable companies have raised at and apply a similar multiple to your own revenue. If B2B SaaS companies at your stage are raising at 15x ARR, and your ARR is $1.5 million, a rough valuation of $22.5 million pre-money is defensible.

The challenge is that "comparable" is contested. Growth rate, gross margin, net revenue retention, market size, and founder pedigree all affect what multiple a company actually achieves. An investor citing a 10x ARR multiple for a company growing at 40% per year and a company growing at 200% per year is using two very different comparables as if they are the same. The median Series A round size by industry in 2026 gives concrete benchmarks you can use to anchor this conversation in real data.

Revenue multiples compress and expand with market conditions. The same company would have achieved a 30x ARR multiple in early 2022 and a 10x multiple in mid-2023. Know where the market is when you are raising, not where it was when someone told you a story about a deal they did three years ago.

3. Scorecard and Berkus Methods (Pre-Revenue)

For companies that have not yet generated revenue, the VC method requires too many assumptions, and revenue multiples do not apply. Pre-revenue valuation is built on qualitative factors that reduce the risk of the bet investors are making.

The Scorecard Method (developed by angel investor Bill Payne) establishes a baseline valuation for the region and stage, then adjusts it up or down based on weighted factors:

• Strength of the founding team: up to 30% weight
• Size of the market opportunity: up to 25% weight
• Product or technology: up to 15% weight
• Competitive environment: up to 10% weight
• Marketing, sales, and partnerships: up to 10% weight
• Need for additional investment: up to 5% weight
• Other factors: up to 5% weight

The Berkus Method is simpler: it assigns a maximum dollar value (up to $500,000 each) to five factors: sound idea, working prototype, quality management team, strategic relationships, and product rollout or early sales. The maximum valuation using Berkus is $2.5 million, which is too low for most markets today, but the framework is useful as a checklist for what de-risks an early-stage company.

Comparison of All Methods

What Actually Moves Your Valuation

Knowing the method is useful. Knowing what inputs move the number is more useful.

Growth rate

Month-over-month and year-over-year growth rate is the single biggest driver of premium valuation in early-stage companies. A company growing at 20% month-over-month will receive a meaningfully higher multiple than one growing at 5%, even if they have the same ARR today.

Net revenue retention

NRR above 100% means your existing customers are paying you more over time, which is evidence of product value and the foundation of efficient growth. Investors pay a significant premium for high NRR because it means new ARR compounds on top of an expanding base. Below 90%, the business is churning customers faster than it adds them, and no growth rate covers that indefinitely.

Gross margin

High gross margin means more of each revenue dollar reaches the bottom line. SaaS and software businesses typically run at 70-85% gross margins, which is why they attract high multiples. Lower-margin businesses in logistics, manufacturing, or consumer goods face compression even with strong growth because the economics of scaling are harder.

Market size and competitive position

Investors need to believe the company can become large. A well-run business in a small market will struggle to achieve the returns a fund needs. Market size matters, and so does whether there is a clear path to leading it.

Frequently Asked Questions

Do investors always tell you how they arrived at your valuation?

Usually not explicitly, but you can ask. Most investors will share their thinking if you ask directly, and understanding their model helps you negotiate more effectively. If an investor cannot explain their valuation, that is worth noting.

What is a fair valuation for a pre-revenue startup in 2026?

Regional averages vary considerably. In the US, pre-seed valuations typically run $3 million to $7 million. In Europe, they are often lower, between $2 million and $5 million. African and Southeast Asian pre-seed companies typically see $1 million to $3 million. These are starting points, not ceilings, and strong teams with clear market evidence regularly exceed them.

Should I negotiate my valuation?

Yes, within reason. Valuation is negotiable, especially at early stages where there is no definitive right answer. The risk of pushing too hard is delaying the close or losing an investor who decides the process is not worth it. The risk of accepting the first number is leaving real money on the table. Come prepared with your own view of the number, grounded in the methods above, and be ready to explain it.

Understanding valuation also requires understanding what dilution looks like at each stage. The guide to how dilution works in startup funding rounds shows how ownership compounds across multiple rounds and why the valuation of each round matters more than it might appear at signing.

Once you have a valuation you are happy with and a term sheet to match, make sure your data room is ready for the diligence that follows. The investor data room checklist covers what investors will ask for at each stage.